IL-23 directly enhances the proliferative and invasive activities of colorectal carcinoma

Oncology Letters

Volumn 4, Issue 2, 2012, Pages 199-204

  Suzuki, Hideyuki ^a   Ogawa, Hitoshi ^a   Miura, Koh ^a   Haneda, Sho ^a   Watanabe, Kazuhiro ^a   Ohnuma, Shinobu ^a   Sasaki, Hiroyuki ^a   Sase, Tomohiko ^a   Kimura, Shunichi ^a   Kajiwara, Taiki ^a   Komura, Toshihiro ^a   Toshima, Masahide ^a   Matsuda, Yasufumi ^a   Shibata, Chikashi ^a   Sasaki, Iwao ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal carcinoma; Interleukin 23; Interleukin 23 receptor; Transforming growth factor

Indexed keywords

INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INVASION; CARCINOGENESIS; CELL CULTURE; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84861992622     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.739     Document Type: Article

References (22)

1. Oppmann B, Lesley R, Blom B, et al: Novel p19protein engages IL-12p40to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725, 2000.
2. Yen D, Cheung J, Scheerens H, et al: IL-23is essential for Tcell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116: 1310-1316, 2006.
3. Sarra M, Pallone F, Macdonald TT, et al: IL-23/IL-17 axis in IBD. Inflamm Bowel Dis 16: 1808-1813, 2010.
4. Monteleone I, Pallone F and Monteleone G: Interleukin-23 and Th17 cells in the control of gut inflammation. Mediators Inflamm 2009: 297645, 2009.
5. Hue S, Ahern P, Buonocore S, et al: Interleukin-23drives innate and T cell-mediated intestinal inflammation. J Exp Med 203: 2473-2483, 2006.
6. Abraham C and Cho J: Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 15: 1090-1100, 2009.
7. Cua DJ, Sherlock J, Chen Y, et al: Interleukin-23rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748, 2003.
8. Parham C, Chirica M, Timans J, et al: A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168: 5699-5708, 2002.
9. Cheung PF, Wong CK and Lam CW: Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J Immunol 180: 5625-5635, 2008.
10. Fukuda M, Ehara M, Suzuki S, et al: IL-23promotes growth and proliferation in human squamous cell carcinoma of the oral cavity. Int J Oncol 36: 1355-1365, 2010.
11. Langowski JL, Zhang X, Wu L, et al: IL-23promotes tumour incidence and growth. Nature 442: 461-465, 2006.
12. Kortylewski M, Xin H, Kujawski M, et al: Regulation of the IL-23and IL-12balance by Stat3signaling in the tumor microenvironment. Cancer Cell 15: 114-123, 2009.
13. Yu H, Pardoll D and Jove R: STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9: 798-809, 2009.
14. Lan F, Zhang L, Wu J, et al: IL-23/IL-23R: potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma. Int J Colorectal Dis 26: 1511-1518, 2011.
15. Meulmeester E and Ten Dijke P: The dynamic roles of TGF-β in cancer. J Pathol 223: 205-218, 2011.
16. Ten Dijke P, Goumans MJ, Itoh F, et al: Regulation of cell proliferation by Smad proteins. J Cell Physiol 191: 1-16, 2002.
17. Tian M and Schiemann WP: The TGF-β paradox in human cancer: an update. Future Oncol 5: 259-271, 2009.
18. Bruna A, Darken RS, Rojo F, et al: High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11: 147-160, 2007.
19. Thiery JP, Acloque H, Huang RY, et al: Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890, 2009.
20. Micalizzi DS, Farabaugh SM and Ford HL: Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15: 117-134, 2010.
21. Su J and Liu YC: Foxp3positive regulatory T cells: a functional regulation by the E3ubiquitin ligase Itch. Semin Immunopathol 32:149-156, 2010.
22. Xu L, Kitani A and Strober W: Molecular mechanisms regulating TGF-β-induced Foxp3 expression. Mucosal Immunol 3: 230-238, 2010.